Finally, the interaction between the corticotrophin-releasing factor (CRF) receptor and 5-HT2A (Magalhaes et al., 2010) further demonstrates that specific signaling outcomes of 5-HT receptors are attractive targets for depression and anxiety treatments. This evidence concerns the gene HTR2A and depressive disorder.